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1. Introduction  
Insomnia is most often defined by an individual's report of sleeping difficulties.[1] One 
definition of insomnia is difficulties in initiating and maintaining sleep, or non-restorative 
sleep, associated with impairments of daytime functioning or marked distress for more than 
1 month."[1,2] insomnia is most often thought of as both a sign[1,3] and a symptom[1,4] that 
can accompany several sleep, medical, and psychiatric disorders, characterized by persistent 
difficulty falling asleep and staying asleep or sleep with bad quality. Specialists in sleep 
medicine have been attempted to diagnose many different sleep disorders. Patients with 
various disorders including delayed sleep phase syndrome are often misdiagnosed as 
primary insomnia. When a person has trouble for getting to sleep but has a normal sleep 
pattern once asleep, circadian rhythm disorder has almost the same cause. In many cases, 
insomnia is co-morbid with another disease, side-effects of medications, or a psychological 
problem. Approximately half of all causes of insomnia are related to psychiatric 
disorders.[1-4] It is possible that insomnia represents a significant risk for the development 
of a subsequent psychiatric disorder."[1] Sleep-onset insomnia is difficulty falling asleep at 
the beginning of the night, often a symptom of anxiety disorders or the delayed sleep phase 
disorder.  
There are two types of insomnia: primary insomnia and secondary insomnia. Primary 
insomnia means that a person having sleep problems that are not directly associated with 
any other health condition or problem. Secondary insomnia means that a person having 
sleep problems because of something else, such as a health condition (like asthma, 
depression, arthritis, cancer, or heartburn); pain; medication they are taking; or a substance 
they are using (like alcohol and other compounds).[5-9] 
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Pharmacological treatments have been used mainly to reduce symptoms in acute insomnia; 
their role in the management of chronic insomnia remains unclear.[1-4]It is important to 
identify or rule out medical and psychological causes before deciding on the treatment for 
insomnia.[1,10] Attention to sleep hygiene is an important first line treatment strategy and 
should be tried before any pharmacological approach is considered.[1,11]  
2. Barbiturates 
Barbiturates are drugs that act as central nervous system depressants. By virtue of this, they 
produce a wide spectrum of effects, from mild sedation to total anesthesia. Barbiturates are 
also effective as anxiolytics, hypnotics, and anticonvulsants.[12] Barbiturates are still widely 
used in surgical anesthesia, especially to induce anesthesia. These compounds are derivatives 
of barbituric acid. Barbituric acid was first synthesized in 1864, by Adolf von Baeyer. The 
synthesis was done by condensing urea (an animal waste product) with diethyl malonate. 
[12,13] Barbiturates were first introduced for medical use in the early 1900s. More than 2,500 
barbiturates have been synthesized, and at the height of their popularity, about 50 were 
marketed for human use. Barbiturates produce a wide spectrum of central nervous system 
depression, from mild sedation to coma, and have been used as sedatives, hypnotics, 
anesthetics, and anticonvulsants. The primary differences among many of these products are 
how fast they produce an effect and how long those effects last. Barbiturates are classified as 
ultra-short, short, intermediate, and long-acting. The Ultra-short barbiturates such as 
thiopental (Pentothal) produce unconsciousness within about a minute of intravenous (IV) 
injection. These drugs may be used to induce general anesthesia. Volatile anesthetics are then 
used to maintain general anesthesia until the end of the operation. Because thiopental and 
other ultrashort-acting barbiturates are typically used in hospital settings, they are not very 
likely to be abused, noted the DEA.[12] Barbiturate abusers prefer the short-acting and 
intermediate-acting barbiturates. After oral administration, the onset of action is from 15 to 40 
minutes, and the effects last up to six hours. These drugs are primarily used for insomnia and 
preoperative sedation. Veterinarians use pentobarbital for anesthesia and euthanasia. Long-
acting barbiturates include phenobarbital (Luminal) and mephobarbital (Mebaral). Effects of 
these drugs are realized in about one hour and last for about 12 hours, and are used primarily 
for daytime sedation and the treatment of seizure disorders. Barbiturates contain a “balance” 
of hydrophilic (2,4,6-pyrimidinetrione ring structure) and lipophilic (5,5’-substituents) 
functionality. The overall hydrophilic (polar) or lipophilic (non-polar) character of the 
barbiturates is a function of: the hydrophilicity of the pyrimidinetrione ring which is a function 
of the number of N-substituents and the pKa of the acidic proton(s), and the overall size and 
structure of the two substituents at the 5-position. (See Fig.-1).[14-19] 
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Common Barbiturates structure 
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2.1 Mechanism of barbiturates action 
The principal mechanism of action of barbiturates is believed to be their affinity for the GABAA 
receptor (acts on GABA (Gamma-aminobutyric acid; H2N(CH2)3COOH):benzodiazepine (BDZ) 
receptor Cl¯ channel complex). The GABA receptors are a class of receptors that respond to 
the neurotransmitter gamma-aminobutyric acid (GABA), the chief inhibitory 
neurotransmitter in the vertebrate central nervous system.[14,15] There are two classes of 
GABA receptors: GABAA and GABAB. GABAA receptors are ligand-gated ion channels (also 
known as ionotropic receptors), whereas GABAB receptors are G protein-coupled receptors 
(also known as metabotropic receptors). Barbiturates bind to the GABAA receptor at the 
alpha subunit, which are binding sites distinct from GABA itself and also distinct from the 
benzodiazepine binding site.[20,21] Like benzodiazepines, barbiturates have similar effect of 
GABA at this receptor. In addition to this GABA-ergic effect, barbiturates also block the 
AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor, a subtype of 
glutamate receptor.[20,21] The AMPA receptor (AMPAR, or quisqualate receptor) is a non 
ionotropic trans-membrane receptor types for glutamate that mediates fast synaptic 
transmission in the central nervous system (CNS). Its name is derived from its ability to be 
activated by the artificial glutamate analog AMPA.[21] Barbiturates produce their 
pharmacological effects by increasing the duration of chloride ion channel opening at the 
GABAA receptor, increases the efficacy of GABA, whereas benzodiazepines increase the 
frequency of the chloride ion channel opening at the GABAA receptor to increase the 
potency of GABA. The direct gating or opening of the chloride ion channel is the reason for 
the increased toxicity of barbiturates compared to benzodiazepines in overdose.[20-23] 
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Barbiturates are relatively non-selective compounds that bind to an entire super-family of 
ligand-gated ion channels, of which the GABAA receptor channel is only one of several 
representatives. While GABAA receptor currents are increased by barbiturates (and other 
general anaesthetic compounds), ligand-gated ion channels that are predominantly 
permeable for cationic ions are blocked by these compounds.[12,24] The findings implicate 
(non-GABA-ergic) ligand-gated ion channels in mediating some of the (side) effects of 
barbiturates.[12,25]  
In 1988, the synthesis and binding study of an artificial receptor binding barbiturates by 6 
complementary hydrogen bonds was published by Chang and Hamilton.[26] According to 
this study, different kinds of receptors were designed, as well as different barbiturates and 
cyanurates, not for their efficiencies as drugs but for applications in supramolecular chemistry, 
in the conception of materials and molecular devices.[12,26] The actions of the barbiturates are 
described in more detail in the Pharmacology Notes. General properties of these compounds 
relatively concern to low “lipophilicity” and low plasma protein binding.[14-20] 
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Fig. 1. The Barbiturates 1-17 structures. 
3. Octanol-water partition coefficient and biodegradation of barbiturates 
The octanol-water partition coefficient (Kow) is a measure of the equilibrium concentration of 
a compound between octanol and water that indicates the potential for partitioning in to soil 
organic matter (i.e., a high Kow indicates a compound which will preferentially partition into 
soil organic matter rather than water). This coefficient is inversely related to the solubility of 
www.intechopen.com
Structural Relationship Study of Octanol-Water Partitioning Coefficients 
and Total Biodegradation of Barbiturate Medicines by Randić Descriptor 
 
103 
a compound in water. The logKow is used in models to estimate plant and soil invertebrate 
bioaccumulation factors. The logKow is commonly used in QSAR studies and drug design, 
since this property is related to drug absorption, bioavailability, metabolism, and toxicity. 
This parameter is also used in many environmental studies to help determine the 
environmental fate of chemicals.[27,28] It has quite a lot of use in medicine and medicinal 
chemistry. Biodegradation (TBd in mol/h)) is another useful and important factors in 
chemical and biochemical studies.[28] 
It needs to use the effective and useful mathematical methods for making good concern 
between several data of chemical properties, medicinal chemistry and biological activity of 
chemicals.  
Graph theory is an attractive field for the exploration of proof techniques in Discrete 
Mathematics and its results have applications in many areas of sciences. A graph is a 
topological concept rather than a geometrical concept of fixed geometry, and hence 
Euclidean metric lengths, angles and three-dimensional spatial configurations have no 
meaning.  
Chemists employ various types of names and formulas when they wish to communicate 
information about chemicals and their structures. For the most part names and formulas 
have no direct, immediate or explicit mathematical meaning. Graph theory provides many 
different methods of characterizing chemical structures numerically.  
It has been found to be a useful tool in QSAR (Quantitative Structure Activity Relationship) 
and QSPR (Quantitative Structure Property Relationship).[29-34] Numerous studies have 
been made relating to the above mentioned fields by using what are called topological 
indices (TI).[34,35]  
In this study, will be considered the relationship of Randić index, for molecular description 
of structure-property relationship studies for the logarithm of calculated Octanol-Water 
partitioning coefficients and total biodegradation (logKow and TBd (mol/h), respectively) in 
Barbiturate compounds (1-17).  
4. Mathematical operations 
The branching index that was introduced by Randić is defined as the sum of certain bond 
contributions calculated from the degree of the bonds suppressed molecular graphs. These 
bond contributions, named Cij are calculated as: 
   Cij = (δi δj)–0.5 (1) 
Where δi is the degree of the vertex representing atom “i”, i.e., the number of bonds incident 
to this atom. Accordingly, the Randić index is defined as: [29,35-38] 
 χ = ΣCij = Σ(δi δj) – 0.5  (2) 
Where the summation is carried out over all the bonds of 1-17.  
The inverse squared–root of the vertex degree is identified here as a measure of the relative 
accessible perimeter of an atom from the outside. These perimeters, which have length units, 
are proposed to be measured in a new unit called the Randić index (χ). On this basis, the 
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bond contributions to the Randić index are relative areas of bond accessibility from the 
environment. 
All graphing operations were performed using the Microsoft Office Excel-2003 program.The 
data of Octanol-Water partitioning coefficients and total biodegradation (logKow and TBd, 
respectively) were calculated by EPI-suit v3.12 package [39]. 
5. Results and discussion 
It was accepted that the organic compounds toxicity properties can be introduced by 
utilizing the logKow.[40] The quantitative structural activities and properties relationship 
results hold true for quite a lot of organic compounds, the most commonly used for test 
organism, follows this standard pattern. [41] Biodegradation is usually quantified by 
incubating a chemical compound in presence of a degrader, and measuring some factors like 
oxygen or production of CO2. The biodegradation QSAR studies demonstrate that microbial 
biosensors are a viable alternative means of reporting on potential biotransformation. 
However, a few chemicals are tested and large data sets for different chemicals need for 
QSAR modeling [42]. This study shows the structural relationship between Randić index (χ), 
logKow and total biodegradation (TBd) for barbiturates (1-17). The values of the relative 
structural coefficients of the barbiturates structures (1-17), Randić index (χ) to logarithm of 
Octanol-Water partitioning coefficients (logKow) and calculated total biodegradation (TBd) in 
mol/h, data were shown in Table-1. The χ values of 1-17 increase with the increasing the 
number of branches in the appropriate structures. The Randić index (χ) for barbituric acid (1) 
in respect with the branches of the structure is equal to 2.1216. See equations 1 and 2 and the 
appropriate data extended in Table-1 for other members of these group. 
χ = 6[(24) – 0.5]= 2.1216 
 
Fig. 2. The linear relationship between the values of log(Kow) versus the Randic Indices (χ) 
for Barbiturates (1-17). 
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No. R1 R2 R3 R4 
Randic 
Indices (χ) Log Kow 
TBd 10-
5 
(mol/h) 
1 H H H H 2.1216 -1.2488 7.2 
2 H H CH3 CH3 3.0166 -0.8264 5.9 
3 CH3 CH3 H H 2.4144 -0.3777 5.9 
4 H H CH3 C2H5 3.4751 -0.1289 5.4 
5 CH3 H C2H5 H 4.0358 0.6045 5.0 
6 (CH2)2CH(CH3)2 C2H5 H H 5.3911 2.0043 4.2 
7 CH(CH3)CH2CH3 C2H5 CH3 H 4.8266 1.7244 4.1 
8 CH(CH3)(CH2)2CH3 C2H5 H H 5.4564 2.0043 4.3 
9 CH(CH3)CH2CH3 C2H5 H H 4.9564 1.5132 4.4 
10 CH(CH3)(CH2)3CH3 H H H 4.7188 1.5508 4.4 
11 CH(CH3)(CH2)3CH3 C2H5 CH3 CH3 5.9978 2.9178 4.4 
12 CH2-CH=CH2 CH(CH3)(CH2)2CH3 H H 5.3152 2.3590 4.0 
13 CH2-CH=CH2 CH(CH3)2 H H 4.5277 1.3768 4.4 
14 CH3 CH3 H 4.3593 1.8548 3.8 
15 C6H5- C2H5 H H 4.8025 1.3301 4.0 
15 C6H5- C2H5 CH3 H 5.0059 1.5413 3.8 
17 C6H5- C2H5 CH3 CH3 4.8761 1.7525 3.6 
Table 1. The values of the relative structural coefficients of Barbiturates structures (1-17). 
In Fig.-2 to Fig.-4 were shown two dimensional diagrams of the relationship between the 
values of Randić index, logKow and TBd. 
The figure 2 shows a good linear relationship between the values of log(Kow) versus the 
Randic Indices (χ) for barbiturates (1-17). The Eq.-3 is relevant to Fig.-2, and as could see by 
this equation can extend the linear behavior of the calculated logKow and χ for these 
compounds. The R-squared value (R2) for this graph is equal to 0.9248. 
 log(Kow) = 1.0309(χ) - 3.3924  (3) 
By this way, equation 3 afford a good approximation for calculation of logarithm value of 
Octanol-Water partitioning coefficient (log Kow) by the use of Randić index (χ) and directly for 
the barbiturates. The large values results for solving the first order Eq.-3 are acceptable. For 
achieving to logKow can use directly from Eq.-3, in accordance with the structural “χ” values 
for these compounds.  
The Fig.-3 shows a curve for relationship between the values of calculated total 
biodegradation (TBd) versus the Randic Indices (χ) for 1-17. The Eq.-4 is relevant to Fig.-4, 
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and can see the non linear behavior of the calculated total biodegradation (TBd) and χ for 
barbiturates (1-17). The equation has three-order structure. The R-squared value (R2) for this 
graph shows 0.8916.  
 TBd = 0.0825(χ)3 - 0.7268(χ)2 + 0.901(χ) + 7.4083  (4) 
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TB d  = 0.0825(X)
3
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Fig. 3. A curve between values of Randić indices (χ) and calculated total biodegradation 
(TBd) for (1-17). 
By the use of Randic Indices (χ) for 1-17 in the Eq.-4 can achieve to an approximation for 
total biodegradation (TBd). All values of TBd should multiply to 10-5 for achieving to 
calculated total biodegradation in mol/h for the compounds. 
A plot of the log(Kow) versus the calculated total biodegradation (TBd) for Barbiturates (1-17) 
was demonstrated in Fig.-4. The equation of this relationship has three-order structure and 
introduced by Eq.-5. The R-squared value (R2) for this graph is equal to 0.9243. 
 TBd = 0.0286(logKow)3 + 0.1884(logKow)2 - 1.1251(logKow) + 5.314 (5) 
It seems that two methods were achieved for TBd calculation of barbiturates (1-17). One of 
these two models, is calculation of Randic Indices (χ) for these important compounds by the 
use of Eq.-4.  
The second method is the measurement of logKow by the use of (χ) in equations 3, then 
utilize the result in Eq.-5. In respect with the R-squared value (R2) for these graphs it is 
obvious that the second model much better for this relationship. Determination of logKow 
and TBd for the barbiturates as an important class of medicinal compounds have highly 
importance and the models that were demonstrated here show simple methods for this 
matter. 
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Fig. 4. A plot of the log(Kow) versus the calculated total biodegradation (TBd) for Barbiturates 
(1-17). 
6. Conclusion 
Barbiturates are primarily used for insomnia and preoperative sedation. These drugs 
contain a “balance” of hydrophilic and lipophilic functionality. General properties of these 
compounds relatively concern to low “lipophilicity” and low plasma protein binding. Graph 
theory has been found to be an effective tool in QSAR and QSPR. Topological inices (TIs) 
contain valuable structural information as evidenced by the success of their widespread 
applications in QSAR. One of the useful descriptors for examination of structure-property 
relationship is Randić index. The lipophilicity and toxicity properties of organic compounds 
can be predicted on the basis of the logKow. The biodegradation QSAR studies demonstrate 
that microbial biosensors are a viable alternative means of reporting on potential 
biotransformation. In this study, was considered the relationship of Randić indeices, 
logarithm of calculated Octanol-Water partitioning coefficients and total biodegradation 
(logKow and TBd (mol/h), respectively) with each other for barbiturates. Randic Indices (χ) 
show a good differences between the values of logKow and TBd as two important factors in 
chemical and biochemical studies in these compounds. 
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